Cite
HARVARD Citation
Kriván, G. et al. (2022). Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency disease. Vox sanguinis. 117 (10), pp. 1153-1162. [Online].